Dennis Charney
Director/Board Member at AMDeC Foundation, Inc.
Dennis Charney active positions
Companies | Position | Start | End |
---|---|---|---|
AMDeC Foundation, Inc. | Director/Board Member | - | - |
New York Genome Center
New York Genome Center Miscellaneous Commercial ServicesCommercial Services New York Genome Center operates as an independent, nonprofit academic research institution that provides genomic research. It provides research on neurodegenerative disease, neuropsychiatric disease, and cancer. The company was founded in 2011 and is headquartered in New York, NY. | Director/Board Member | - | - |
Mount Sinai Genomics, Inc.
Mount Sinai Genomics, Inc. Medical/Nursing ServicesHealth Services Mount Sinai Genomics, Inc. operates online predictive health analysis platform for diagnosis, treatment and prevention of diseases. It offers Centrellis which analyzes and interprets extensive information about known inherited diseases, including related mutations, frequency across populations, and the penetrance and expressivity of genetic changes. The company was founded by Eric Schadt and is headquartered in Stamford, CT. | Director/Board Member | - | - |
The Mount Sinai Health System, Inc.
The Mount Sinai Health System, Inc. Medical/Nursing ServicesHealth Services The Mount Sinai Health System, Inc. provides health care system services. It is an integrated health care system providing exceptional medical care to our local and global communities. The company is headquartered in New York, NY. | Corporate Officer/Principal | 31/08/2013 | - |
Icahn School of Medicine at Mount Sinai | Corporate Officer/Principal | 31/12/2003 | - |
CastleVax, Inc.
CastleVax, Inc. BiotechnologyHealth Technology CastleVax, Inc. is an American vaccine platform company based on technology developed at the Icahn School of Medicine at Mount Sinai, headquartered in an undisclosed location. The private company's platform uses a disease virus to induce the human immune system to produce neutralizing antibodies targeted at a range of emerging and pandemic viruses, including SARS-CoV-2. The technology was developed in response to the growing need for vaccine independence and pandemic response preparedness. CastleVax's leading candidate, NDV-HXP-S, is currently being tested in clinical trials in multiple countries around the world. The company was founded by Florian Krammer, Peter Palese, Adolfo García-Sastre. | Director/Board Member | - | - |
Career history of Dennis Charney
Former positions of Dennis Charney
Companies | Position | Start | End |
---|---|---|---|
GENEDX HOLDINGS CORP. | Director/Board Member | 21/07/2021 | 13/06/2023 |
Independent Dir/Board Member | 21/07/2021 | 13/06/2023 | |
Yale University | Corporate Officer/Principal | 31/12/1989 | 31/12/1999 |
National Institute of Mental Health | Corporate Officer/Principal | - | - |
Training of Dennis Charney
Pennsylvania State University College of Medicine | Doctorate Degree |
Rutgers State University of New Jersey | Undergraduate Degree |
Statistics
International
United States | 12 |
Operational
Director/Board Member | 5 |
Corporate Officer/Principal | 4 |
Independent Dir/Board Member | 1 |
Sectoral
Consumer Services | 5 |
Health Services | 4 |
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
GENEDX HOLDINGS CORP. | Health Services |
Private companies | 6 |
---|---|
AMDeC Foundation, Inc. | |
New York Genome Center
New York Genome Center Miscellaneous Commercial ServicesCommercial Services New York Genome Center operates as an independent, nonprofit academic research institution that provides genomic research. It provides research on neurodegenerative disease, neuropsychiatric disease, and cancer. The company was founded in 2011 and is headquartered in New York, NY. | Commercial Services |
Mount Sinai Genomics, Inc.
Mount Sinai Genomics, Inc. Medical/Nursing ServicesHealth Services Mount Sinai Genomics, Inc. operates online predictive health analysis platform for diagnosis, treatment and prevention of diseases. It offers Centrellis which analyzes and interprets extensive information about known inherited diseases, including related mutations, frequency across populations, and the penetrance and expressivity of genetic changes. The company was founded by Eric Schadt and is headquartered in Stamford, CT. | Health Services |
The Mount Sinai Health System, Inc.
The Mount Sinai Health System, Inc. Medical/Nursing ServicesHealth Services The Mount Sinai Health System, Inc. provides health care system services. It is an integrated health care system providing exceptional medical care to our local and global communities. The company is headquartered in New York, NY. | Health Services |
National Institute of Mental Health | Government |
CastleVax, Inc.
CastleVax, Inc. BiotechnologyHealth Technology CastleVax, Inc. is an American vaccine platform company based on technology developed at the Icahn School of Medicine at Mount Sinai, headquartered in an undisclosed location. The private company's platform uses a disease virus to induce the human immune system to produce neutralizing antibodies targeted at a range of emerging and pandemic viruses, including SARS-CoV-2. The technology was developed in response to the growing need for vaccine independence and pandemic response preparedness. CastleVax's leading candidate, NDV-HXP-S, is currently being tested in clinical trials in multiple countries around the world. The company was founded by Florian Krammer, Peter Palese, Adolfo García-Sastre. | Health Technology |
- Stock Market
- Insiders
- Dennis Charney
- Experience